Selected research
Industry Research
Antacid Tablet Industry Research Report 2026
Market perspective
The global Antacid Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antacid Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antacid Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antacid Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antacid Tablet include GSK, Bayer, WellSpring Pharmaceutical Corporation, Walmart（Equate）, Thornton & Ross Ltd, PG, McNeil Consumer Pharmaceuticals, Chattem and Boehringer Ingelheim Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antacid Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antacid Tablet Market by Company
GSK
Bayer
WellSpring Pharmaceutical Corporation
Walmart（Equate）
Thornton & Ross Ltd
PG
McNeil Consumer Pharmaceuticals
Chattem
Boehringer Ingelheim Pharmaceuticals
Antacid Tablet Segment by Type
Mg Based Antacid Tablet
Ca Based Antacid Tablet
Mixed Antacid Tablet
Antacid Tablet Segment by Application
In-Patient
Out-Patient
Antacid Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacid Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antacid Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacid Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antacid Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antacid Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antacid Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mg Based Antacid Tablet
- Ca Based Antacid Tablet
- Mixed Antacid Tablet
Applications
- In-Patient
- Out-Patient
Companies covered
- GSK
- Bayer
- WellSpring Pharmaceutical Corporation
- Walmart（Equate）
- Thornton & Ross Ltd
- PG
- McNeil Consumer Pharmaceuticals
- Chattem
- Boehringer Ingelheim Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antacid Tablet Market Size (2021-2032)
- 2.2.2 Global Antacid Tablet Sales (2021-2032)
- 2.2.3 Global Antacid Tablet Market Average Price (2021-2032)
- 2.3 Antacid Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mg Based Antacid Tablet
- 2.3.3 Ca Based Antacid Tablet
- 2.3.4 Mixed Antacid Tablet
- 2.4 Antacid Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 In-Patient
- 2.4.3 Out-Patient
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antacid Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antacid Tablet Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Antacid Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Antacid Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Antacid Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antacid Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antacid Tablet, Product Type & Application
- 3.8 Global Manufacturers of Antacid Tablet, Established Date
- 3.9 Global Antacid Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Antacid Tablet Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Bayer
- 4.2.1 Bayer Company Information
- 4.2.2 Bayer Business Overview
- 4.2.3 Bayer Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Antacid Tablet Product Portfolio
- 4.2.5 Bayer Recent Developments
- 4.3 WellSpring Pharmaceutical Corporation
- 4.3.1 WellSpring Pharmaceutical Corporation Company Information
- 4.3.2 WellSpring Pharmaceutical Corporation Business Overview
- 4.3.3 WellSpring Pharmaceutical Corporation Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 WellSpring Pharmaceutical Corporation Antacid Tablet Product Portfolio
- 4.3.5 WellSpring Pharmaceutical Corporation Recent Developments
- 4.4 Walmart（Equate）
- 4.4.1 Walmart（Equate） Company Information
- 4.4.2 Walmart（Equate） Business Overview
- 4.4.3 Walmart（Equate） Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Walmart（Equate） Antacid Tablet Product Portfolio
- 4.4.5 Walmart（Equate） Recent Developments
- 4.5 Thornton & Ross Ltd
- 4.5.1 Thornton & Ross Ltd Company Information
- 4.5.2 Thornton & Ross Ltd Business Overview
- 4.5.3 Thornton & Ross Ltd Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Thornton & Ross Ltd Antacid Tablet Product Portfolio
- 4.5.5 Thornton & Ross Ltd Recent Developments
- 4.6 PG
- 4.6.1 PG Company Information
- 4.6.2 PG Business Overview
- 4.6.3 PG Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PG Antacid Tablet Product Portfolio
- 4.6.5 PG Recent Developments
- 4.7 McNeil Consumer Pharmaceuticals
- 4.7.1 McNeil Consumer Pharmaceuticals Company Information
- 4.7.2 McNeil Consumer Pharmaceuticals Business Overview
- 4.7.3 McNeil Consumer Pharmaceuticals Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 McNeil Consumer Pharmaceuticals Antacid Tablet Product Portfolio
- 4.7.5 McNeil Consumer Pharmaceuticals Recent Developments
- 4.8 Chattem
- 4.8.1 Chattem Company Information
- 4.8.2 Chattem Business Overview
- 4.8.3 Chattem Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chattem Antacid Tablet Product Portfolio
- 4.8.5 Chattem Recent Developments
- 4.9 Boehringer Ingelheim Pharmaceuticals
- 4.9.1 Boehringer Ingelheim Pharmaceuticals Company Information
- 4.9.2 Boehringer Ingelheim Pharmaceuticals Business Overview
- 4.9.3 Boehringer Ingelheim Pharmaceuticals Antacid Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Pharmaceuticals Antacid Tablet Product Portfolio
- 4.9.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
5 Global Antacid Tablet Market Scenario by Region
- 5.1 Global Antacid Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antacid Tablet Sales by Region: 2021-2032
- 5.2.1 Global Antacid Tablet Sales by Region: 2021-2026
- 5.2.2 Global Antacid Tablet Sales by Region: 2027-2032
- 5.3 Global Antacid Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Antacid Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Antacid Tablet Revenue by Region: 2027-2032
- 5.4 North America Antacid Tablet Market Facts & Figures by Country
- 5.4.1 North America Antacid Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antacid Tablet Sales by Country (2021-2032)
- 5.4.3 North America Antacid Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antacid Tablet Market Facts & Figures by Country
- 5.5.1 Europe Antacid Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antacid Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Antacid Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Antacid Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antacid Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antacid Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antacid Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antacid Tablet Market Facts & Figures by Country
- 5.7.1 South America Antacid Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antacid Tablet Sales by Country (2021-2032)
- 5.7.3 South America Antacid Tablet Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Antacid Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antacid Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antacid Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antacid Tablet Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antacid Tablet Sales by Type (2021-2032)
- 6.1.1 Global Antacid Tablet Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Antacid Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Antacid Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Antacid Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antacid Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Antacid Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antacid Tablet Sales by Application (2021-2032)
- 7.1.1 Global Antacid Tablet Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Antacid Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Antacid Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Antacid Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antacid Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Antacid Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antacid Tablet Value Chain Analysis
- 8.1.1 Antacid Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antacid Tablet Production Mode & Process
- 8.2 Antacid Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antacid Tablet Distributors
- 8.2.3 Antacid Tablet Customers
9 Global Antacid Tablet Analyzing Market Dynamics
- 9.1 Antacid Tablet Industry Trends
- 9.2 Antacid Tablet Industry Drivers
- 9.3 Antacid Tablet Industry Opportunities and Challenges
- 9.4 Antacid Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst